NZ Rheumatology Research Review Issue 21

In this issue:

Light physical activity helps prevent disability
A role for bisphosphonates in OA?
Outcome predictors for knee synovitis in RA
Milnacipran beneficial in fibromyalgia
Golimumab: sustained efficacy in active AS
Bisphosphonates vs infliximab in AS
Brodalumab looks promising in PsA
Tofacitinib versus methotrexate in RA
Apremilast effective and safe in PsA
Which treatment strategy is best in new-onset RA?

Please login below to download this issue (PDF)